Management Team

BURT D. ENSLEY has been a Director of the Company since its inception in 1993. From 2000 to the present, Dr. Ensley has served as the VP of Research and President of NuCycle Therapy, a subsidiary of Integrated BioPharma, a publicly traded (INB) nutraceutical Company. From 1993 through 2000, Dr. Ensley was President, Chief Executive Officer and Director of Phytotech, Inc. A phytoremediation company. Phytotech was sold in 2000. From 1989 through 1992, Dr. Ensley served as Director of Advanced Technology at Envirogen, Inc., a microbial based bioremediation company. From 1981 to 1989, Dr. Ensley headed the Specialty Chemicals Group at Amgen, Inc. Dr. Ensley received a B.S. and M.S. in Biology from the University of New Mexico in 1974 and 1976 and a Ph.D. in Microbiology from the University of Georgia in 1979. Since 1996, Dr. Ensley serves on the National Science Foundation’s BIO Directorate Advisory Board and as a Fellow of the American Academy of Microbiology.

LORENZO A. DELUCA has served as a Director since April 2004. Mr. DeLuca is the owner and President of Paxton Ventures Corp., a venture capital and consulting firm specializing in emerging growth companies. In connection with Paxton’s portfolio investments, Mr. DeLuca has served as officer or director of Action Industries Inc., General Vision Services, Inc., Bio-Reference Laboratories and Merchants Advantage.com. Mr. DeLuca is an attorney admitted to practice in the State of New York and was a founding member of Zervas & DeLuca. Mr. DeLuca received a BA degree from Rutgers College and a J.D. degree from New York Law School.